Abstract
MKC-231, a putative cholinergic activity, is reported to improve learning and memory impaired in AF64A-treated animals. MKC-231 enhances high-affinity choline uptake (HACU) known as the rate-limiting step of acetylcholine (ACh) synthesis. We investigated the mode of action (MOA) of HACU enhancement by MKC-231. Intracerebroventricular (i.c.v.) injections of AF64A (3 nmol/brain) resulted in significant HACU reduction in hippocampal synaptosomes. Treatment with MKC-231 increased V max of HACU and B max of [3H]-HC-3 binding 1.6 and 1.7-fold, respectively. In studies of [3H]-MKC-231 binding and Biacore analysis, MKC-231 showed noticeable affinity for cloned high-affinity choline transporters (CHT1). The present study suggests that MKC-231 directly affects trafficking of CHT1 and increases the numbers of transporter, working for HACU, at the synaptic membrane.
Similar content being viewed by others
References
Aarsland D, Mosimann UP, McKeith IG (2004) Role of cholinesterase inhibitors in Parkinson’s disease and dementia with Lewy bodies. J Geriatr Psychiatry Neurol 17:164–171
Abdiche YN, Myszka DG (2004) Probing the mechanism of drug/lipid membrane interactions using Biacore. Anal Biochem 328:233–243
Bessho T, Takashina K, Tabata R, Oshima C, Chaki H, Yamabe H, Egawa M, Tobe A, Saito K-I (1996) Effects of the novel high affinity choline uptake enhancer 2-(2-oxopyrrolidin-1-yl)-N-(2, 3-dimethyl-5, 6, 7, 8-tetrahydrofuro[2, 3-b]quinolin-4-yl) acetoamide on deficits of water maze learning in rats. Arzneimittelforschung 46:369–373
Bessho T, Takashina K, Eguchi J, Komatsu T, Saito K-I (2008) MKC-231, a choline-uptake enhancer: (1) long-lasting cognitive improvement after repeated administration in AF64A-treated rats. J Neural Transm. doi:10.1007/s00702-008-0053-4
Chrobak JJ, Hanin I, Schmechel TJ, Walsh TJ (1988) AF64A-induced working memory impairment: behavioral, neurochemical and histological correlates. Brain Res 463:107–117
Collerton D (1986) Cholinergic function and intellectual decline in Alzheimer’s disease. Neuroscience 19:1–28
Cooper MA, Hansson A, Löfås S, Williams DH (2000) A vesicle capture sensor chip for kinetic analysis of interactions with membrane-bound receptors. Anal Biochem 277:196–205
Ferguson SM, Savchenko V, Apparsundaram S, Zwick M, Wright J, Heilman CJ, Yi H, Levey AI, Blakely RD (2003) Vesicular localization and activity-dependent trafficking of presynaptic choline transporters. J Neurosci 23:9697–9709
Ferguson SM, Blakely RD (2004) The choline transporter resurfaces: new roles for synaptic vesicles? Mol Interv 4:22–37
Fisher A, Mantione CR, Abraham DJ, Hanin I (1982) Long-term central cholinergic hypofunction induced in mice by ethylcholine aziridinium ion (AF64A) in vivo. J Pharmacol Exp Ther 222:140–145
Gower AJ, Rousseau D, Jamsin P, Gobert J, Hanin I, Wulfert E (1989) Behavioral and histological effects of low concentrations of intraventricular AF64A. Eur J Pharmacol 166:271–281
Guo Q, Fu W, Xie J, Luo H, Sells SF, Geddes JW, Bondada V, Rangnekar VM, Mattson MP (1998) Par-4 is a mediator of neuronal degeneration associated with the pathogenesis of Alzheimer disease. Nat Med 4:957–962
Ivy MT, Newkirk RF, Karim MR, Mtshali CMP, Townsel JG (2001) Hemicholinium-3 mustard reveals two populations of cycling choline cotransporters in Limulus. Neuroscience 102:969–978
Jenden DJ, Jope RS, Weiler MH (1976) Regulation of acetylcholine synthesis: does cytoplasmic acetylcholine control high affinity choline uptake? Science 194:635–637
Krištofiková Z, Fales E, Majer E, Klaschka J (1995) (3H) Hemicholinium-3 binding sites in postmortem brains of human patients with Alzheimer’s disease and multi-infarct dementia. Exp Gerontol 30:125–136
Kuhar MJ, Murrin LC (1978) Sodium dependent, high affinity choline uptake. J Neurochem 30:15–21
Murai S, Saito H, Abe E, Masuda Y, Odashima J, Itoh T (1994) MKC-231, a choline uptake enhancer, ameliorates working memory deficits and decreased hippocampal acetylcholine induced by ethylcholine aziridinium ion in mice. J Neural Trasm 98:1–13
Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates, 2nd edn. Academic Press, New York
Quirion R (1987) Characterization and autoradiographic distribution of hemicholinium-3 high-affinity choline uptake sites in mammalian brain. Synapse 1:293–303
Ribeiro FM, Alves-Silva J, Volknandt W, Martins-Silva C, Mahmud H, Wilhelm A, Gomez MV, Rylett RJ, Ferguson SSG, Prado VF, Prado MAM (2003) The hemicholinium-3 sensitive high affinity choline transport is internalized by clathrin-mediated endocytosis and is present in endosomes and synaptic vesicle. J Neurochem 87:136–146
Ribeiro FM, Black SAG, Cregan SP, Prado VF, Prado MAM, Rylett RJ, Ferguson SSG (2005) Constitutive high-affinity choline transporter endocytosis is determined by a carboxyl-terminal tail dileucine motif. J Neurochem 94:86–96
Ribeiro FM, Black SAG, Cregan SP, Prado VF, Prado VF, Rylett RJ, Ferguson SSG, Prado MAM (2006) The ‘ins’ and ‘outs’ of high-affinity choline transporter. J Neurochem 97:1–12
Ribeiro FM, Ferreira LT, Marion S, Fontes S, Gomez M, Fergason SS, Prado MA, Prado VF (2007) SEC14-like protein interacts with cholinergic transpoters. Neurochem Int 50:356–364
Rodriguez-Puertas R, Pazos A, Zarranz JJ, Pascual J (1994) Selective cortical decrease of high-affinity choline uptake carrier in Alzheimer’s disease: autoradiographic study using 3H-hemicholinium-3. J Neural Transm 8:161–169
Rylett RJ, Ball MJ, Colhoun EH (1983) Evidence for high affinity choline transport in synaptosomes prepared from hippocampus and neocortex of patients with Alzheimer’s disease. Brain Res 289:169–175
Rylett RJ, Davis W, Walters SA (1993) Modulation of high-affinity choline carrier activity following incubation of rat hippocampal synaptosomes with hemicholinium-3. Brain Res 626:184–189
Simon JR, Kuhar MJ (1975) Impulse-flow regulation of high affinity choline uptake in brain cholinergic nerve terminals. Nature 255:162–163
Simon JR, Atweh S, Kuhar MJ (1976) Sodium-dependent high affinity choline uptake: a regulatory step in the synthesis of acetylcholine. J Neurochem 26:909–922
Sims NR, Bowen DM, Allen SJ, Smith CCT, Neary D, Thomas DJ, Davison AN (1983) Presynaptic cholinergic dysfunction in patients with dementia. J Neurochem 40:503–509
Slotkin TA, Seidler FJ, Crain BJ, Bell JM, Bissette G, Nemeroff CB (1990) Regulatory changes in presynaptic cholinergic function assessed in rapid autopsy material from patients with Alzheimer disease: Implications for etiology and therapy. Proc Natl Acad Sci 87:2452–2455
Stip E, Chouinard S, Boulay LJ (2005) On the trail of a cognitive enhancer for the treatment of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 29(2):219–232
Takashina K, Bessho T, Mori R, Kawai K, Eguchi J, Saito K-I (2008) MKC-231, a choline uptake enhancer: (3) mode of action of MKC-231 in the enhancement of high-affinity choline uptake. J Neural Transm. doi: 10.1007/s00702-008-0049-0
Terry AV Jr, Buccafusco JJ (2003) The cholinergic hypothesis of age and Alzheimer’s disease-related cognitive deficits: Recent challenges and their implications for novel drug development. J Pharmacol Exp Ther 306:821–827
Xie J, Guo Q (2004) Par-4 inhibits choline uptake by interacting with CHT1 and reducing its incorporation on the plasma membrane. J Biol Chem 279(27):28266–28275
Yamamura HI, Snyder SH (1973) High affinity transport of choline into synaptosomes of rat brain. J Neurochem 21:1355–1374
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Takashina, K., Bessho, T., Mori, R. et al. MKC-231, a choline uptake enhancer: (3) mode of action of MKC-231 in the enhancement of high-affinity choline uptake. J Neural Transm 115, 1037–1046 (2008). https://doi.org/10.1007/s00702-008-0049-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00702-008-0049-0